Home/Memgen/Gregory Brown, MD, MBA
GB

Gregory Brown, MD, MBA

Chief Executive Officer, Director

Memgen

Therapeutic Areas

Memgen Pipeline

DrugIndicationPhase
MEM-288Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)Phase 1